EIF4E and melanoma: Therefore, by demonstrating that CXCR7 is capable of accelerating HIF-1α translation by promoting Src-mediated eIF4E phosphorylation (Fig. 6f), our findings raise the possibility of interfering with this axis as clinical therapeutics for melanoma patients.